updated graphical abstract.pdf (583.1 kB)
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor
Version 2 2024-02-12, 09:48
Version 1 2023-12-19, 10:59
media
posted on 2024-02-12, 09:48 authored by Adis Journals on Behalf of:, Marc Evans, Mansoor Husain, Ayush Srivastava, Kamal Kant Mangla, Anja Birk Kuhlman, Ildiko LingvayThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
